MESOTHELIOMA MALIGNANT

MESOTHELIOMA MALIGNANT was reported 369 times

These drug classes are most commonly taken by patients reporting MESOTHELIOMA MALIGNANT:

# Drug Count
0 Corticosteroid [EPC] 29
1 Folate Analog Metabolic Inhibitor [EPC] 16
2 Nonsteroidal Anti-inflammatory Drug [EPC] 14
3 Platinum-based Drug [EPC] 11
4 Vitamin B12 [EPC] 10
5 Vitamin C [EPC] 10
6 Vitamin D [EPC] 9
7 Proton Pump Inhibitor [EPC] 8
8 Tumor Necrosis Factor Blocker [EPC] 8
9 Benzodiazepine [EPC] 7
10 Osmotic Laxative [EPC] 7
11 HMG-CoA Reductase Inhibitor [EPC] 6
12 Platelet Aggregation Inhibitor [EPC] 6
13 Proteasome Inhibitor [EPC] 6
14 Thalidomide Analog [EPC] 6
15 Angiotensin 2 Receptor Blocker [EPC] 5
16 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5
17 Loop Diuretic [EPC] 5
18 Vascular Endothelial Growth Factor Inhibitor [EPC] 5
19 Alkaloid [EPC] 4
20 CD38-directed Cytolytic Antibody [EPC] 4
21 Calcineurin Inhibitor Immunosuppressant [EPC] 4
22 Dihydropyridine Calcium Channel Blocker [EPC] 4
23 Factor Xa Inhibitor [EPC] 4
24 Provitamin D2 Compound [EPC] 4
25 Thiazide Diuretic [EPC] 4
26 beta-Adrenergic Blocker [EPC] 4
27 Aldosterone Antagonist [EPC] 3
28 Alkylating Drug [EPC] 3
29 Antirheumatic Agent [EPC] 3
30 Calcium Channel Blocker [EPC] 3
31 Erythropoiesis-stimulating Agent [EPC] 3
32 Potassium Salt [EPC] 3
33 Amide Local Anesthetic [EPC] 2
34 Angiotensin Converting Enzyme Inhibitor [EPC] 2
35 Antiarrhythmic [EPC] 2
36 Atypical Antipsychotic [EPC] 2
37 CD20-directed Cytolytic Antibody [EPC] 2
38 Calcium [EPC] 2
39 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
40 Endothelin Receptor Antagonist [EPC] 2
41 Insulin Analog [EPC] 2
42 Insulin [EPC] 2
43 Integrin Receptor Antagonist [EPC] 2
44 Interleukin-5 Antagonist [EPC] 2
45 Janus Kinase Inhibitor [EPC] 2
46 Opioid Agonist [EPC] 2
47 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
48 Prostacycline Vasodilator [EPC] 2
49 Prostaglandin Analog [EPC] 2
50 Sulfonamide Antimicrobial [EPC] 2
51 Sulfonylurea [EPC] 2
52 Xanthine Oxidase Inhibitor [EPC] 2
53 alpha-Adrenergic Blocker [EPC] 2
54 Androgen Receptor Inhibitor [EPC] 1
55 Anti-epileptic Agent [EPC] 1
56 Antimetabolite Immunosuppressant [EPC] 1
57 Aromatic Amino Acid [EPC] 1
58 Azole Antifungal [EPC] 1
59 Bile Acid Sequestrant [EPC] 1
60 CD19-directed Chimeric Antigen Receptor [EPC] 1
61 Cardiac Glycoside [EPC] 1
62 Central Nervous System Stimulant [EPC] 1
63 Chloride Channel Activator [EPC] 1
64 Cholinergic Nicotinic Agonist [EPC] 1
65 Dietary Cholesterol Absorption Inhibitor [EPC] 1
66 Ester Local Anesthetic [EPC] 1
67 Estrogen [EPC] 1
68 Genetically-modified Autologous T Cells [EPC] 1
69 Glinide [EPC] 1
70 Guanylate Cyclase-C Agonist [EPC] 1
71 Histamine-2 Receptor Antagonist [EPC] 1
72 Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] 1
73 Interleukin-1 Receptor Antagonist [EPC] 1
74 Interleukin-17A Antagonist [EPC] 1
75 Methylxanthine [EPC] 1
76 Monoamine Oxidase Inhibitor [EPC] 1
77 Monoamine Oxidase Type B Inhibitor [EPC] 1
78 Muscle Relaxant [EPC] 1
79 Neonatal Fc Receptor Blocker [EPC] 1
80 Nitrate Vasodilator [EPC] 1
81 Non-Standardized Chemical Allergen [EPC] 1
82 P2Y12 Platelet Inhibitor [EPC] 1
83 Phenothiazine [EPC] 1
84 Phosphodiesterase 5 Inhibitor [EPC] 1
85 Purine Antimetabolite [EPC] 1
86 Recombinant Human Deoxyribonuclease 1 [EPC] 1
87 Serotonin-3 Receptor Antagonist [EPC] 1
88 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
89 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1
90 Thiazide-like Diuretic [EPC] 1
91 Thyroid Hormone Synthesis Inhibitor [EPC] 1
92 Vasopressin V2 Receptor Antagonist [EPC] 1